Abstract
Progressive increases in the worldwide number of cases of brain diseases accompanied by cognitive impairments continually reinforce the relevance of the need for further investigation and pharmacotherapy of this type of neuromental pathology, particularly as this problem has great significance, not only in the medical sphere, but also in the social. This explains the currently extensive interest of investigators of different specialties in studies of the role of the hippocampus (HPO) in the genesis of these disorders and the possibility that nootropic substances have influences on it.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
